Considering the degree of insulin resistance, MHO-MetS patients that were insulin sensitive had a significantly better metabolic profile, not only compared to MUO, but also compared to insulin resistant MHO-MetS (e.g., patients classified as “healthy” according to MetS criteria). This evidence concerns the gene INS and metabolic syndrome.